Corrigendum to: “A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease” [J Hepatol 79 (2023) 394-402]
Journal of Hepatology
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Citation
Corrigendum to: “A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease” [J Hepatol 79 (2023) 394-402]. // Journal of Hepatology. – URL: https://www.sciencedirect.com/science/article/pii/S016882782602711X?dgcid=rss_sd_all
Corrigendum to: “A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease” [J Hepatol 79 (2023) 394-402]. Journal of Hepatology. https://www.sciencedirect.com/science/article/pii/S016882782602711X?dgcid=rss_sd_all
“Corrigendum to: “A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease” [J Hepatol 79 (2023) 394-402].” Journal of Hepatology.
@article{article53480,
title = {Corrigendum to: “A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease” [J Hepatol 79 (2023) 394-402]},
journal = {Journal of Hepatology},
url = {https://www.sciencedirect.com/science/article/pii/S016882782602711X?dgcid=rss_sd_all}
}